Metabolism of chlorpromazine and promazine in vitro: Isolation and characterization of N-oxidation products

References

• Beckett A. H. The metabolism of chlorpromazine and promethazine to give -pink spots'. Proposals for the mechanisms involved. Xenobiotica 1975; 5: 449–452
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Essien E. E. Chlorpromazine -hydroxylamines’ in red blood cells as major metabolites of chlorpromazine in man. Journal of Pharmacy and Pharmacology 1973; 25: 188–189
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Hewick D. S. The N-oxidation of chlorpromazine in vitro—the major metabolic route using rat liver microsomes. Journal of Pharmacy and Pharmacology 1967; 19: 134–136
   Web of Science ®Google Scholar
• Beckett A. H., Hutt A. J. In vitro metabolism in the rabbit of desipramine and nortriptyline to yield carboxylic acids. Journal of Pharmacy and Pharmacology 1982; 34: 614
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Hutt A. J., Navas G. E. Metabolism of imipramine in vitro: synthesis and characterization of N-hydroxydesmethylimipramine. Xenobiotica 1983; 13: 391–405
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Jones G. R., Hollingsbee D. A. Degradation of ( - )-ephedrine in solution and during extraction with diethylether. Journal of Pharmacy and Pharmacology 1978; 30: 15–19
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Navas G. E. Aromatic oxidation of some phenothiazines. Xenobiotica 1978a; 8: 721–736
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Navas G. E. Synthesis and properties of N-hydroxy compounds of aminoalkyl phenothiazines. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier/North Holland Biomedical Press, Amsterdam 1978b; 455–460
   Google Scholar
• Bickel M. H. Metabolism and structure-activity relationships of thymoleptic drugs. Antidepressant Drugs Proceedings of the First International Symposium. Excerpta Medica Foundation, 1967; 3–9, International Congress Series No. 122
   Google Scholar
• Borch R. F., Bernstein M. D., Hurst H. D. The cyanohydridoborate anion as a selective reducing agent. Journal of the American Chemical Society 1971; 93: 2897–2904
   Web of Science ®Google Scholar
• Bornschein I., Pfeifer S. Zur Biotransformation von Promazin. Pharmazie 1980; 35: 441
   PubMedGoogle Scholar
• Cho A. K., Duncan J. D., Fukuto J. M., Lindeke B. The metabolic disposition of organonitrogen compounds. Foreign Compound Metabolism, J. Caldwell, G. D. Paulson. Taylor & Francis, London 1984; 79–89
   Google Scholar
• Appendix 1: Reagents. Isolation and Identification of Drugs, E. G. C. Clarke. The Pharmaceutical Press, London 1969; 799, 801
   Google Scholar
• Clement B., Beckett A. H. Synthesis of some metabolites of promethazine. Arch. Pharmazie 1981a; 314: 716–722
   Web of Science ®Google Scholar
• Clement B., Beckett A. H. Metabolism of promethazine in vitro Identification of N-oxidized products. Xenobiotica 1981b; 11: 609–618
   PubMed Web of Science ®Google Scholar
• Coutts R. T., Beckett A. H. Metabolic N-oxidation of primary and secondary aliphatic medicinal amines. Drug Metabolism Reviews 1977; 6: 51–104
   Web of Science ®Google Scholar
• Fishman V., Heaton A., Goldenberg H. Metabolism of chlorpromazine III. Isolation and identification of chlorpromazine N-oxide. Proceedings of the Society of Experimental Biology & Medicine 1962; 109: 548–552
   PubMed Web of Science ®Google Scholar
• Godefroi E. F., Wittle E. L. The preparation of some derivatives of β-(10-phenothiazinyl)propionic acid and β-(2-chloro-10-phenothiazinyl)propionic acid. Journal of Organic Chemistry 1956; 21: 1163–1168
   Web of Science ®Google Scholar
• Goldenberg H., Fishman V. Metabolism of chlorpromazine. V. Confirmation of position 7 as the major site of hydroxylation. Biochemical and Biophysical Research Communications 1964; 14: 404–407
   PubMed Web of Science ®Google Scholar
• Biological Oxidation of Nitrogen in Organic Molecules, Chemistry, Toxicology and Pharmacology, J. W. Gorrod, L. A. Damani. Chichester, Ellis Horwood 1985
   Google Scholar
• Gram L. F. Metabolism of tricyclic antidepressants. A review. Danish Medical Bulletin 1974; 21: 218–321
   PubMed Web of Science ®Google Scholar
• Green D. E., Forrest I. S., Forrest F. M., Serra M. T. Inter-patient variation in chlorpromazine metabolism. Experimental Medicine and Surgery 1965; 23: 278–287
   PubMedGoogle Scholar
• Hutt A. J., Navas G. E., Beckett A. H. Metabolic oxidation of desmethylchlorimipramine in vitro by 9000g rabbit liver preparations. Xenobiotica 1982; 12: 645–655
   PubMed Web of Science ®Google Scholar
• Lehman J. P., Fenselau C., Depaulo J. R. Quaternary ammonium-linked glucuronides of amitriptyline, imipramine and chlorpromazine. Drug Metabolism and Disposition 1983; 11: 221–225
   PubMed Web of Science ®Google Scholar
• Meltzer H. Y., Fang V. S., Simonovich M., Paul S. M. Effect of metabolites of chlorpromazine on plasma prolactin levels in male rats. European Journal of Pharmacology 1977; 41: 431–436
   PubMed Web of Science ®Google Scholar
• Morgan P. H., Beckett A. H. Synthesis of some N-oxygenated products of 3,4-dimethoxyamphetamine and its N-alkyl derivatives. Tetrahedron 1975; 31: 2595–2601
   Web of Science ®Google Scholar
• Özkirimli S., Cowan D. A., Beckett A. H. In vitro metabolism of desmethyltrimipramine to yield hydroxylamino compound. Acta Pharmaceutica Suecica 1986; 23: 57–59
   PubMedGoogle Scholar
• Pfeifer S. Promazinum. Biotransformation von Arzneimitteln. Verlag Chemie, Weinheim 1977a; Band 1: 363–365
   Google Scholar
• Pfeifer S. Chlorpromazinum. Biotransformation von Arzneimitteln. Verlag Chemie, Weinheim 1977b; Band 2: 93–104
   Google Scholar
• Pfeifer S. Chlorpromazium. Biotransformation von Arzneimitteln. Verlag Chemie, Weinheim 1983; Band 5: 220–224
   Google Scholar
• Pfeifer S., Jany G., Zöpfel H. -J. Weitere Ring-sulfonmetaboliten von Phenothiazin Arzneimitteln. Pharmazie 1982; 37: 522
   PubMedGoogle Scholar
• Vogel A. I. Practical Organic Chemistry3rd Edition. Longmans, Green and Co., London 1956; 330, 1061
   Google Scholar
• Wilhelm M. The chemistry of polycyclic psycho-active drugs—serendipity or systematic investigation. Pharmaceutical Journal 1975; 214: 414–416
   Google Scholar
• Ziegler D. M. Molecular basis for N-oxygenation of sec- and tert-amines. Biological Oxidation of Nitrogen in Organic Molecules, Chemistry, Toxicology and Pharmacology, J. W. Gorrod, L. A. Damani. Ellis Horwood, Chichester 1985; 43–52
   Google Scholar